Classification, diagnosis and treatment of vascular dementia

Drugs and Aging

Volumn 11, Issue 5, 1997, Pages 361-373

  Konno, Shizuko ^a   Meyer, John Stirling ^a,b   Terayama, Yasuo ^a   Margishvili, Gaiane M ^a   Mortel, Karl F ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; PENTOXIFYLLINE; TICLOPIDINE;

AGED; BINSWANGER ENCEPHALOPATHY; BRAIN INFARCTION; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; DIABETES MELLITUS; DISEASE CLASSIFICATION; ESTROGEN THERAPY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MULTIINFARCT DEMENTIA; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SMOKING CESSATION;

EID: 0030773732     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-199711050-00004     Document Type: Review

References (83)

1. Tomlinson BE, Blessed G, Roth M. Observations of the brains of demented old people. J Neurol Sci 1970; 11: 205-42
2. Jellinger K. Neuropathological aspects of dementias resulting from abnormal blood and cerebrospinal fluid dynamics. Acta Neurol Belg 1976; 76: 83-102
3. Schoenberg BS. Epidemiology of vascular dementia and multi-infarct dementia. In: Meyer JS, Lechner H, Marshall J, et al., editors. Vascular and multi-infarct dementia. Mt Kisco (NY): Futura Publishing Co., 1988: 47-59
4. Ueda K, Hasuo Y, Fujishima M. Prevalence and etiology of dementia in a Japanese community. Stroke 1992; 23: 798-803
5. Yoshitake T, Kiyohara Y, Kato I, et al. Incidence and risk factor of vascular dementia and Alzheimer's disease in a defined elderly Japanese population. Neurology 1995; 45: 1161-8
6. Skoog I, Nilsson L, Palmertz B, et al. A population-based study of dementia in 85-year-olds. N Engl J Med 1993; 328: 153-8
7. Meyer JS, Judd BW, Tawaklna T, et al. Improved cognition after control of risk factors for multi-infarct dementia. JAMA 1986; 256: 2203-9
8. Meyer JS, McClintic K, Sims P, et al. Etiology, prevention, and treatment of vascular and multi-infarct dementia. In: Meyer JS, Lechner H, Marshall J, et al., editors. Vascular and multi-infarct dementia. Mt Kisco (NY): Futura Publishing Co., 1988: 129-47
9. Meyer JS, Rogers RL, McClintic K, et al. Randomized clinical trial of daily aspirin therapy in multi-infarct dementia. J Am Geriatr Soc 1989; 37: 549-55
10. Meyer JS. Differential diagnosis, etiology, pathophysiology and treatment of multi-infarct dementia. Recent Adv Cardiovasc Dis 1990; 11 Suppl. 1: 83-9
11. Meyer JS, Muramatsu K, Mortel KF, et al. Prospective CT confirms differences between vascular and Alzheimer's dementia. Stroke 1995; 26: 735-42
12. Hachinski VC. Preventable senility: a call for action against the vascular dementias. Lancet 1992; 340: 645-8
13. Loeb C, Meyer JS. Vascular dementia: still a debatable entity? J Neurol Sci 1996; 143: 31-40
14. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994
15. WHO. International statistical classification of related health problems, 10th revision (ICD-10). Geneva: WHO, 1992
16. Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop. Neurology 1993; 43: 250-60
17. Chui HC, Victoroff JI, Margolin D, et al. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology 1992; 42: 473-80
18. Desmond DW. Vascular dementia: a construct in evolution. Cerebrovasc Brain Metab Rev 1996; 8: 296-325
19. Tatemichi TK, Desmond DW, Mayeux R, et al. Dementia after stroke: baseline frequency, risks, and clinical features in a hospitalized cohort. Neurology 1992; 42: 1185-93
20. Meyer JS, McClintic KL, Rogers RL, et al. Aetiological considerations and risk factors for multi-infarct dementia. J Neurol Neurosurg Psychiatry 1988; 51: 1489-97
21. Skoos I. Risk factors for vascular dementia: a review. Dementia 1994; 5: 137-44
22. Lindsay J, Hébert R, Rockwood K. The Canadian Study of Health and Aging: risk factors for vascular dementia. Stroke 1997; 28: 526-30
23. Johansson BB. Pathogenesis of vascular dementia: the possible role of hypertension. Dementia 1994; 5: 174-6
24. Desmond DW, Tatemichi TK, Paik M, et al. Risk factors for cerebrovascular disease as correlates of cognitive function in a stroke-free cohort. Arch Neurol 1993; 50: 162-6
25. Tatemichi TK, Desmond DW, Paik M, et al. Clinical determinants of dementia related to stroke. Ann Neurol 1993; 33: 568-75
26. Ott A, Breteler MMB, Bruyne MC, et al. Atrial fibrillation and dementia in a population-based study: the Rotterdam Study. Stroke 1997; 28: 316-21
27. Gorelick PB, Brody J, Cohen D, et al. Risk factors for dementia associated with multiple cerebral infarcts: a case-control analysis in predominantly African-American hospital-based patients. Arch Neurol 1993; 50: 714-20
28. Rockwood K, Ebly E, Hachinski V, et al. Presence and treatment of vascular risk factors in patients with vascular cognitive impairment. Arch Neurol 1997; 54: 33-9
29. Tatemichi TK, Paik M, Bagiella MS, et al. Risk of dementia after stroke in a hospitalized cohort: result of a longitudinal study. Neurology 1994; 44: 1885-91
30. Mortel KF, Meyer JS, Herod B, et al. Education and occupation as risk factors for dementias of the Alzheimer and ischemic vascular types. Dementia 1995; 6: 55-62
31. Gorelick PB. Status of risk factors for dementia associated with stroke. Stroke 1997; 28: 459-63
32. Plassman BL, Breitner CS. Recent advances in the genetics of Alzheimer's disease and vascular dementia with an emphasis on gene-environment interactions. J Am Geriatr Soc 1996; 44: 1242-50
33. Moroney JT, Bagiella E, Desmond DW, et al. Risk factors for incident dementia after stroke: role of hypoxic and ischemic disorders. Stroke 1996; 27: 1283-9
34. Mortel KF, Meyer JS. Lack of postmenopausal estrogen replacement therapy and the risk of dementia. J Neuropsychiatry Clin Neurosci 1995; 7: 334-7
35. Meyer JS, Rogers RL, Judd BW, et al. Cognition and cerebral blood fluctuate together in multi-infarct dementia. Stroke 1988; 19: 163-9
36. Meyer JS. The nature of reduced cerebral perfusion in vascular and multi-infarct dementia. In: Meyer JS, Lechner H, Marshall J, editors. Vascular and multi-infarct dementia. Mt Kisco (NY): Futura Publishing Co., 1988: 113-27
37. Loeb C. Vascular dementia. Dementia 1990; 1: 175-84
38. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984; 34: 939-44
39. Hachinski VC, Iliff LD, Zilhka E, et al. Cerebral blood flow in dementia. Arch Neurol 1975; 32: 632-7
40. O'Brien MD. Vascular dementia is underdiagnosed. Arch Neurol 1988; 45: 797-8
41. Blacker D, Albert MS, Bassett SS, et al. Reliability and validity of NINCDS-ADRDA criteria for Alzheimer's disease: the National Institute of Mental Health Genetics Initiative. Arch Neurol 1994; 51: 1198-204
42. Erkinjuntti T. Clinical criteria for vascular dementia: the NINDS-AIREN criteria. Dementia 1994; 5: 189-92
43. Tierney MC, Fisher RH, Lewis AJ, et al. The NINCDS-ADRDA work group criteria for clinical diagnosis of probable Alzheimer's disease: a clinicopathologic study of 57 cases. Neurology 1988; 38: 359-64
44. Erkinjuntti T. Accuracy of the clinical diagnosis of vascular dementia: a prospective clinical and post-mortem neuropathological study. J Neurol Neurosurg Psychiatry 1988; 51: 1037-44
45. Kukull WA, Larson EB, Reifler BV, et al. The validity of three clinical diagnostic criteria for Alzheimer's disease. Neurology 1990; 40: 1364-89
46. Risse SC, Raskind MA, Nochlin D. Neuropathological findings in patients with clinical diagnoses of probable Alzheimer's disease. Am J Psychiatry 1990; 147: 168-72
47. Jellinger K, Danielczyk W, Fischer P, et al. Clinicopathological analysis of dementia disorders in the elderly. J Neurol Sci 1990; 95: 239-58
48. Lopez OL, Larumbe MR, Becker JT, et al. Reliability of NINDS-AIREN clinical criteria for the diagnosis of vascular dementia. Neurology 1994; 44: 1240-5
49. Wetterling T, Kanitz RD, Borgis KJ. Comparison of different diagnostic criteria for vascular dementia (ADDTC, DSM-IV, ICD-10, NINDS-AIREN). Stroke 1996; 27: 30-6
50. Wade JPH, Mirsen TR, Hachinski VC, et al. The clinical diagnosis of Alzheimer's disease. Arch Neurol 1987; 44: 24-9
51. O'Brien MD. Vascular dementia: problems with nomenclature, definition, and classification. J Stroke Cerebrovasc Dis 1994; 4: 52-6
52. Wallin A, Blennow K. The clinical diagnosis of vascular dementia. Dementia 1994; 5: 181-4
53. Brun A. Pathology and pathophysiology of cerebrovascular dementia: pure subgroups of obstructive and hypoperfusive etiology. Dementia 1994; 5: 145-7
54. Meyer JS, Shirai T, Akiyama H. Vascular dementia. In: Welch KMA, Caplan L, Reis D, et al., editors. Primer on cerebrovascular disease. San Diego: Academic Press Inc., 1997: 364-6
55. Tatemichi TK. How acute brain failure becomes chronic: a view of the mechanisms of dementia related to stroke. Neurology 1990; 40: 1652-9
56. Loeb C, Gandolfo C, Croce R, et al. Dementia associated with lacunar infarction. Stroke 1992; 23: 1225-9
57. Roman GC. From UBOs to Binswanger's disease: impact of magnetic resonance imacing on vascular dementia research. Stroke 1996; 27: 1269-73
58. Caplan LR. Binswanser's disease-revisited. Neurology 1995; 45: 626-33
59. Tournier-Lasserve E, Iba-Zizen MT, Romero N, et al. Autosomal dominant syndrome with strokelike episodes and leukoencephalopathy. Stroke 1991; 22: 1297-302
60. Bousser MG, Tournier-Lasserve E. Summary of the proceedings of the first international workshop on CADASIL: Paris, May 19-21, 1993. Stroke 1994; 25: 704-5
61. You R, McNeil JJ, O'Malley HM, et al. Risk factors for lacunar infarction syndromes. Neurology 1995; 45: 1483-7
62. Skoog I, Lernfelt B, Landahl S, et al. 15-Year longitudinal study of blood pressure and dementia. Lancet 1996; 347: 1141-5
63. Shaw TG, Mortel KF, Meyer JS, et al. Cerebral blood flow changes in benign aging and cerebrovascular disease. Neurology 1984; 34: 855-62
64. Masawa N, Yoshida Y, Yamada T, et al. Morphometry of structural preservation of tunica media in aged and hypertensive human intracerebral arteries. Stroke 1994; 25: 122-7
65. Watanabe N, Imai Y, Nagai K, et al. Nocturnal blood pressure and silent cerebrovascular lesions in elderly Japanese. Stroke 1996; 27: 1319-27
66. Meyer JS, Muramatsu K, Shirai T, et al. Cerebral embolism as a cause of stroke and transient ischemic attacks. Echocardiography 1996; 13: 513-7
67. Stroke Prevention in Atrial Fibrillation Investigators. Stroke prevention in atrial fibrillation study: final results. Circulation 1991; 84: 527-34
68. Stroke Prevention in Atrial Fibrillation Investigators. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study. Lancet 1994; 343: 687-91
69. Van Bergen PFMM, Jonker JJC, van der Meer FJM, et al., and the Anticoagulants in the Secondary Prevention of Events in Coronary Thrombosis (ASPECT) Research Group. Effect of long-term anticoagulant treatment on mortality and cardiovascular morbidity after myocardial infarction. Lancet 1994; 343: 499-503
70. Smith P, Arnesen H, Holme I. The effect of warfarin on mortality and reinfarction after myocardial infarction. N Engl J Med 1990; 323: 147-52
71. Azar AJ, Koudstaal PJ, Wintzen AR, et al. Risk of stroke during long-term anticoagulant therapy in patients after myocardial infarction. Ann Neurol 1996; 39: 301-7
72. Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973-5
73. Kistler JP, Buonanno FS, Gress DR. Carotid endarterectomy: specific therapy based on pathophysiolosy. N Engl J Med 1991; 325: 505-7
74. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991; 325: 445-53
75. Desmond DW, Moroney JT, Sano M, et al. Recovery of cognitive function after stroke. Stroke 1996; 27: 1798-803
76. Wolf PA. Cigarettes, alcohol and stroke. N Engl J Med 1986; 315: 1087-9
77. Gorelick PB, Rodin MB, Langenberg P, et al. Weekly alcohol consumption, cigarette smoking, and the risk of ischemic stroke: results of a case-control study at three urban medical centers in Chicago, Illinois. Neurology 1989; 39: 339-43
78. Rogers RL, Meyer JS, Shaw TG, et al. Cigarette smoking decreases cerebral blood flow suggesting increased risk for stroke. JAMA 1983; 250: 2796-800
79. Rogers RL, Meyer JS, Judd BW, et al. Abstention from cigarette smoking improves cerebral perfusion among elderly chronic smokers. JAMA 1985; 253: 2970-4
80. Birge SJ. Is there a role for estrogen replacement therapy in the prevention and treatment of dementia? J Am Geriatr Soc 1996; 44: 865-70
81. Hass WK, Easton JD, Adams HP, et al., for the Ticlopidine Aspirin Stroke Study Group. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. N Engl J Med 1989; 321: 501-7
82. Black RS, Barclay LL, Nolan KA, et al. Pentoxifylline in cerebrovascular dementia. J Am Geriatr Soc 1992; 40: 237-44
83. Molnar FJ, Dalziel WB. The pharmacoeconomics of dementia therapies. Drugs Aging 1997 Mar; 10 (3): 219-33